Drugs / EPAX 1050TG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00211159 | Dec 2000 → ? | Alzheimer disease | Karolinska University Hospital | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPAX 1050TG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00211159 ↗ |
| Modality | Other / unclassified | “dietary supplementation with a preparation, rich in DHA” NCT00211159 ↗ |
| Route | Oral | “oral supplementation with omega-3 (n-3) FAs” PMID 24410954 ↗ Jan 2014 |